EurekAlert!: Overcoming PARP inhibitor resistance in triple-negative breast cancer: the fatty acid synthase way
Overcoming PARP inhibitor resistance in triple-negative breast cancer: the fatty acid synthase way
An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic dysfunction-associated steatohepatitis (MASH) in a phase II clinical trial. In ...
ascopubs.org: A phase I, open-label, dose-finding study of fatty acid synthase (FASN) inhibitor TVB-2640 administered in combination with enzalutamide (Enza) in men with metastatic ...
A phase I, open-label, dose-finding study of fatty acid synthase (FASN) inhibitor TVB-2640 administered in combination with enzalutamide (Enza) in men with metastatic ...
Scientists at UC Irvine have found a way to potentially reverse age-related vision loss by targeting the ELOVL2 “aging gene” and restoring vital fatty acids in the retina. Their experiments in mice ...
Marine microorganisms have emerged as promising biological factories for the synthesis of valuable fatty acids, notably polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and ...
The raw material for de novo fatty acid synthesis is acetyl-CoA, which can be obtained via the citrate shuttle pathway or from acetic acid. ACC and FASN catalyze the conversion of acetyl-CoA into ...
The Scientist: Cancer Cells Need Fatty Acids to Survive in the Brain
Medium- and short-chain fatty acids (C8-C14) are widely used in industries including food, pharmaceuticals, lubricants, and surfactants, and they are currently mainly extracted from coconut and palm ...
AZOM: Using NIRS to Determine Iodine Value and Fatty Acid Profile in Palm Oil
Using NIRS to Determine Iodine Value and Fatty Acid Profile in Palm Oil